Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Farmorubicin Epirubicin Hydrochloride Injection 10 mg
Farmorubicin Epirubicin Hydrochloride Injection 10 mg is a potent anti-cancer agent utilized in the treatment of various malignancies. Epirubicin hydrochloride, the active ingredient, is a member of the anthracycline family of drugs. It exerts its therapeutic effects by disrupting the DNA replication process in cancer cells, thereby inhibiting tumor growth and proliferation.
Uses of Farmorubicin Epirubicin Hydrochloride Injection 10 mg
Breast Cancer: Often used in the treatment of both early and advanced breast cancer, including as part of combination chemotherapy regimens.
Ovarian Cancer: Employed in the treatment of advanced ovarian cancer, particularly in combination with other chemotherapy agents.
Lung Cancer: Utilized in the management of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) as part of combination chemotherapy.
Gastric Cancer: Effective in treating advanced gastric cancer, often in combination with other chemotherapeutic agents.
Soft Tissue Sarcomas: Used in the treatment of various soft tissue sarcomas, including as an adjuvant therapy.
Benefits of Farmorubicin Epirubicin Hydrochloride Injection 10 mg
Effective Anti-Cancer Activity: Proven efficacy in treating a wide range of cancers by inhibiting DNA synthesis in cancer cells.
Combination Therapy: Can be used in combination with other chemotherapy agents to enhance overall treatment effectiveness.
Advanced Cancer Management: Suitable for managing both early and advanced stages of various malignancies.
Intravenous Administration: Administered directly into the bloodstream, ensuring rapid distribution and effectiveness.
Improved Outcomes: Contributes to better patient outcomes by reducing tumor size and inhibiting cancer cell proliferation.
Mechanism of Action of Farmorubicin Epirubicin Hydrochloride Injection 10 mg
Epirubicin hydrochloride functions by intercalating into the DNA of cancer cells, disrupting the DNA double helix structure. This intercalation prevents the DNA from unwinding and replicating, effectively blocking the process of DNA synthesis and repair. Additionally, Epirubicin generates free radicals that cause further damage to cancer cell DNA. This combined action leads to cancer cell death and suppression of tumor growth. The drugs ability to target rapidly dividing cancer cells makes it a powerful agent in chemotherapy regimens.